StockData
Aura Biosciences, Inc. logo

Aura Biosciences, Inc. (AURA) stock

AURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$7.15−0.07 (-0.97%)

Close on Nov 17, 2026Market cap $741.49MP/E –Yield –

Aura Biosciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Aura Biosciences's market cap was $787.48M on Nov 11, 2026, against $415.70M a year earlier. Over the last 5 years it ranged from $7.52M to $787.48M, with a median of $391.01M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$787.48M+129.4%
2025Dec 31, 2025$343.27M-16.1%
2024Dec 31, 2024$409.18M+20.8%
2023Dec 29, 2023$338.60M+10.1%
2022Dec 30, 2022$307.47M+3990.2%
2021Dec 31, 2021$7.52M–

More Aura Biosciences figures

See a number that looks wrong?